Skip to main content
Clinical Trials/IRCT20210608051515N2
IRCT20210608051515N2CompletedPhase 2

Evaluation of the Effectiveness of Antidepressant Agents, Venlafaxine Versus Sertraline in Patients with Epilepsy and Depression

Tehran University of Medical Sciences0 sites30 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 75 years (—)
Sex
All

Inclusion Criteria

  • Definite Diagnosis of Epilepsy based on Clinical Findings and Neurologist View
  • Positive Evaluation of Depression based on NDDI-E Questionnaire
  • Clinical Diagnosis of Moderate to Severe Depression Using Hamilton Depression Scale

Exclusion Criteria

  • Suicide Attempt in Recent Year
  • Alcohol or Substance Abuse
  • History of a Complex Mood Disorder e.g. Bipolar Disorder
  • Other Accompanying Neurological Disease
  • Evidence of Hypersensitivity to SSRIs
  • Hypertension
  • Major Kidney or Liver Dysfunction
  • Active Hemorrhage
  • Pregnancy and Breast-feeding

Investigators

Similar Trials